臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"tsai m c"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 36-60 / 455 (共19页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2022-04-28T12:31:09Z	Comparison of four healthy lifestyle scores for predicting cardiovascular events in a national cohort study	Tsai M.-C.; Yeh T.-L.; Hsu H.-Y.; Hsu L.-Y.; Lee C.-C.; Tseng P.-J.; KUO-LIONG CHIEN
臺大學術典藏	2022-04-28T12:31:09Z	Lipid biomarkers and Cancer risk - a population-based prospective cohort study in Taiwan	Chang Y.-C.; Lin C.-J.; Yeh T.-L.; Tsai M.-C.; Hsu L.-Y.; KUO-LIONG CHIEN; Hsu H.-Y.
臺大學術典藏	2022-04-28T12:31:08Z	Increased standardised incidence ratio of cardiovascular diseases among colorectal cancer patients	Hsu H.-Y.; Chern Y.-J.; Hsieh C.-T.; Yeh T.-L.; Tsai M.-C.; Wang C.-C.; Hsiao B.-Y.; Jhuang J.-R.; Chiang C.-J.; Lee W.-C.; KUO-LIONG CHIEN
臺大學術典藏	2022-04-26T06:18:08Z	Automatic Kidney Volume Estimation System Using Transfer Learning Techniques	Hsiao C.-H;Tsai M.-C;Lin F.Y.-S;Lin P.-C;Yang F.-J;Yang S.-Y;Wang S.-Y;Liu P.-R;Huang Y.; Hsiao C.-H; Tsai M.-C; Lin F.Y.-S; Lin P.-C; Yang F.-J; Yang S.-Y; Wang S.-Y; Liu P.-R; Huang Y.; YEONG-SUNG LIN
臺大學術典藏	2022-04-21T06:51:52Z	Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-Deprenyl in vivo	Liou H.-H.; Chen R.-C.; Chen, Tony Hsiu Hsi; Tsai Y.-F.; Tsai M.-C.
臺大學術典藏	2022-04-21T06:51:26Z	Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: Geographic variations among 502 villages in southern Taiwan	Tsai M.-C.; Kee K.-M.; Chen Y.-D.; Lin L.-C.; Tsai L.-S.; Chen, Tony Hsiu Hsi; Lu S.-N.
臺大學術典藏	2022-04-21T06:50:48Z	Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy	Chang K.-C.; Wu Y.-Y.; Hung C.-H.; Lu S.-N.; Lee C.-M.; Chiu K.-W.; Tsai M.-C.; Tseng P.-L.; Huang C.-M.; Cho C.-L.; Chen, Tony Hsiu Hsi; Hu T.-H.
臺大學術典藏	2022-04-21T06:50:39Z	A polymorphism in interferon L3 Is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis c virus infection	Chang K.-C.; Tseng P.-L.; Wu Y.-Y.; Hung H.-C.; Huang C.-M.; Lu S.-N.; Wang J.-H.; Lee C.-M.; Chen C.-H.; Tsai M.-C.; Yen Y.-H.; Lin M.-T.; Wu C.-K.; Huang C.-C.; Chen, Tony Hsiu Hsi; Hu T.-H.
臺大學術典藏	2022-04-20T08:12:02Z	Increased standardised incidence ratio of cardiovascular diseases among colorectal cancer patients	Hsu H.-Y.; Chern Y.-J.; Hsieh C.-T.; Yeh T.-L.; Tsai M.-C.; Wang C.-C.; Hsiao B.-Y.; Jhuang J.-R.; CHUN-JU CHIANG; Lee W.-C.; Chien K.-L.
臺大學術典藏	2022-04-15T03:14:32Z	Est1p as a cell cycle-regulated activator of telomere-bound telomerase	SHU-CHUN TENG; Tsai H.-J.; Tsai M.-C.; Lee W.-M.; Chen I.-C.; Lin C.-C.
臺大學術典藏	2022-03-30T05:44:42Z	Designed a new workstation and flowmeter for local ventilation	Tsai M.-C.; JIA-KUN CHEN; Tseng T.-I.
臺大學術典藏	2022-03-17T06:36:25Z	Gastrointestinal: Afferent loop syndrome	Herbella F.A.M.; Lee T.-C.; Matone J.; Del Grande J.C.; Liu K.-L.; Tsai M.-C.; MING-TAI LIN; Wang H.-P.
臺大學術典藏	2022-02-23T08:10:48Z	Biofunctionalized magnetic nanoparticles for in vitro labeling and in vivo locating specific biomolecules	Wu C.C.; Lin L.Y.; Lin L.C.; HUI-CHUN HUANG; Yang Y.F.; Liu Y.B.; Tsai M.C.; Gao Y.L.; Wang W.C.; Hung S.W.; Yang S.Y.; Horng H.E.; Yang H.C.; Tseng W.Y.I.; Yeh H.I.; Hsuan C.F.; Lee T.L.; Tseng W.K.
臺大學術典藏	2022-02-23T08:10:47Z	Two-dimensional propagation of magnetocardiac T wave signals for characterizing myocardial ischemia	Wu C.C.; HUI-CHUN HUANG; Liu Y.B.; Lin L.C.; Lin L.Y.; Chen M.F.; Tsai M.C.; Gao Y.L.; Yang S.Y.; Horng H.E.; Yang H.C.; Tseng W.K.; Lee T.L.; Hsuan C.F.; Pan Y.F.; Lee Y.H.
臺大學術典藏	2022-02-23T02:12:22Z	Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment	Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN; Hsu C.-S.; Hui Y.T.; Li M.K.K.; Liu C.-H.; Kan Y.-M.; Yu M.-L.; Yuen M.-F.
臺大學術典藏	2022-02-23T02:12:21Z	Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan	Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; CHIEN-HUNG CHEN; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigators
臺大學術典藏	2022-02-23T02:12:21Z	Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment	Lin M.-T.; Chang K.-C.; Yen Y.-H.; Tsai M.-C.; CHIEN-HUNG CHEN; Wang J.-H.; Hsiao C.-C.; Chiu Y.-H.; Hu T.-H.
臺大學術典藏	2022-02-23T02:12:17Z	Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection	Tsai M.-C.; Wang C.-C.; Lee W.-C.; Lin C.-C.; Chang K.-C.; CHIEN-HUNG CHEN; Hung C.-H.; Lin M.-T.; Hsiao C.-C.; Chen C.-L.; Chien R.-N.; Hu T.-H.
臺大學術典藏	2022-02-22T05:34:11Z	Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment	Lin M.-T.; Chang K.-C.; Yen Y.-H.; Tsai M.-C.; CHIEN-HUNG CHEN; Wang J.-H.; Hsiao C.-C.; Chiu Y.-H.; Hu T.-H.
臺大學術典藏	2022-02-22T05:34:11Z	Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment	Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN; Hsu C.-S.; Hui Y.T.; Li M.K.K.; Liu C.-H.; Kan Y.-M.; Yu M.-L.; Yuen M.-F.
臺大學術典藏	2022-02-22T05:34:10Z	Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan	Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; CHIEN-HUNG CHEN; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigators
臺大學術典藏	2022-02-22T05:34:07Z	Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection	Tsai M.-C.; Wang C.-C.; Lee W.-C.; Lin C.-C.; Chang K.-C.; CHIEN-HUNG CHEN; Hung C.-H.; Lin M.-T.; Hsiao C.-C.; Chen C.-L.; Chien R.-N.; Hu T.-H.
臺大學術典藏	2022-02-14T06:28:45Z	Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment	Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H.
臺大學術典藏	2022-02-14T06:28:42Z	Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan	Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.‐Y.; Kao J.-H.
臺大學術典藏	2022-02-14T06:28:42Z	Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis	Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H.

显示项目 36-60 / 455 (共19页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :2828323
	造访人次 : 32250328 在线人数 : 1060 教育部委托研究计画计画执行:国立台湾大学图书馆